Aptuit appoints Jonathan Goldman CEO
This article was originally published in Scrip
Executive Summary
Early to mid-phase drug development service provider Aptuit has named Dr Johnathan Goldman chief executive officer. Dr Goldman joins the Greenwich, Connecticut-based company from contract research firm ICON, where he was executive vice-president of global strategic and business development. Dr Goldman is also an associate clinical professor of medicine in the division of cardiology at the University of California.
You may also be interested in...
Accessing Venture Debt From The EIB
Tips from Gergely Krajcsi, senior investment officer at the European Investment Bank, on how biotechs can access loans for faster growth.
In Vivo's 2024 Rising Leaders At A Glance
Top 30 leaders: see the list of industry influencers highlighted in the fifth edition of In Vivo's Rising Leaders series.
In Vivo’s 2024 Rising Leaders
The fifth annual listing of In Vivo’s Rising Leaders includes entrepreneurs and innovators from across the world who represent the next wave of creativity in health care.